What is the current Granisetron Market size?

The Granisetron Market is projected to register a CAGR of 6.20% during the forecast period (2024-2029) Read More

Who are the key players in Granisetron Market?

Kyowa Kirin Co., Ltd., Heron Therapeutics, Inc., Viatris, Hikma Pharmaceuticals PLC and Fresenius SE & Co. KGaA are the major companies operating in the Granisetron Market. Read More

Which is the fastest growing region in Granisetron Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Granisetron Market?

In 2024, the North America accounts for the largest market share in Granisetron Market. Read More

What years does this Granisetron Market cover?

The report covers the Granisetron Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Granisetron Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Granisetron Market Share

Statistics for the 2023 & 2024 Granisetron market share, created by Mordor Intelligence™ Industry Reports. Granisetron share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Granisetron Industry

The granisetron market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. Some of the major players in the market are Kyowo Kirin Co. Ltd, Heron Therapeutics, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals, and Viatris. The key market players are strategically involved in various activities, such as product launches, collaborations, and expansions, in order to improve their product portfolio.